CN Stock MarketDetailed Quotes

300363 Porton Pharma Solutions

Watchlist
  • 11.87
  • +0.05+0.42%
Trading Jul 26 14:37 CST
6.48BMarket Cap-49049P/E (TTM)

Porton Pharma Solutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Porton Pharma Solutions Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

677.72M

-50.81%
EPS(YoY)

-0.17

-130.36%
Analyst Rating

Strong Buy

Jul 26, 2024

Porton Pharma Solutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 590.000M--
--2024/Q2-- / 1.118B--
--2024/Q1677.718M / 653.000M--
--2023/Q4630.414M / 621.000M--
--2023/Q3698.257M / 796.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 590.000M--
--2024/Q2-- / 1.118B--
--2024/Q1677.718M / 653.000M--
--2023/Q4630.414M / 621.000M--
--2023/Q3698.257M / 796.000M--

Unlock Free Earnings Estimates

Porton Pharma Solutions Earnings Reports

  • Porton Pharma Solutions: 2024 First Quarter Report

    Apr 26 12:00 ET

  • Porton Pharma Solutions: 2023 Annual Report Summary

    Apr 26 12:00 ET

  • Porton Pharma Solutions: 2023 ANNUAL REPORT

    Apr 26 12:00 ET

  • Boteng shares: 2023 performance forecast

    Jan 26 03:42 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Strong Buy

    • Strong Buy

      87.50%

    • Buy

      12.50%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg